Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-17

Clinical Trial Update: Acid Reflux and Stromal Fibroblasts in Barrett's Esophagus [Phase 1]

View source ↗

Summary

Phase 1 trial examining the role of acid reflux and stromal fibroblasts in Barrett's Esophagus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Barrett's Esophagus, GERD | Phase 1 | Status: COMPLETED